Sagamihara, Japan

Noriko Matsuyama


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Noriko Matsuyama

Introduction: Noriko Matsuyama, an accomplished inventor based in Sagamihara, Japan, has made significant contributions to the field of biomedical research. Her innovative work focuses on developing methodologies that enhance the efficacy of medical therapies, particularly in the area of interferon treatment.

Latest Patents: Noriko Matsuyama holds one notable patent titled "Polymorphic Marker that Can Be Used to Assess the Efficacy of Interferon Therapy." This invention provides a polymorphic marker identified in the interferon receptor gene region, which can effectively evaluate the success of interferon therapy in individuals. The patent also outlines various methods for assessing therapy efficacy and proposes means to implement such methods in clinical settings.

Career Highlights: Matsuyama's career is outstanding, as she has honed her skills and expertise while working at Kabushiki Kaisha Toshiba. Her role at the company enables her to push the boundaries of biomedical innovation and lead initiatives that are essential for advancements in treatment methodologies.

Collaborations: Throughout her career, Noriko Matsuyama has collaborated with esteemed colleagues, including Masanobu Sugimoto and Michie Hashimoto. These partnerships have significantly contributed to her innovative projects, fostering an environment of knowledge sharing and collective expertise.

Conclusion: Noriko Matsuyama exemplifies the spirit of innovation within the medical field. Her contributions, particularly through her patent related to interferon therapy, reflect her dedication to improving patient outcomes and advancing biomedical technology. As she continues her work at Kabushiki Kaisha Toshiba, her influence is likely to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…